Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

FDA Commissioner Marty Makary and Dr. Vinay Prasad outlined their booster shot clinical trial requirements in the New England Journal of Medicine.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...